Survival Improvements in Adolescents and Young Adults following Myeloablative Allogeneic Transplantation for Acute Lymphoblastic Leukemia

Adolescents and young adults (AYAs, ages 15–40 years) with cancer have not experienced survival improvements to the same extent as younger and older patients. We compared changes in survival following myeloablative allogeneic hematopoietic cell transplantation (HCT) for acute lymphoblastic leukemia...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Wood, William A., Lee, Stephanie J., Brazauskas, Ruta, Wang, Zhiwei, Aljurf, Mahmoud D., Ballen, Karen K., Buchbinder, David K., Dehn, Jason, Freytes, Cesar O., Lazarus, Hillard M., LeMaistre, Charles F., Mehta, Paulette, Szwajcer, David, Joffe, Steven, Majhail, Navneet S.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4019683/
https://ncbi.nlm.nih.gov/pubmed/24607554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.02.021
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki